Flomics Biotech
PrivateLast Round
Crowdfunding
Jul 12, 2024
Est. Valuation
$10.67M
Total Funding Raised
$3.18M
Company Overview
Flomics Biotech is a biotechnology company that develops liquid biopsy tests for the early detection of cancer and other complex diseases using cell-free RNA and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flomics Biotech Comparables
Compare Flomics Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resero Bio, Inc. | 83% | |
| MultiplAI Health | 77% | |
| Elypta | 77% |
Flomics Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jul 12, 2024 | ||||
| Seed | Mar 6, 2024 | ||||
| Seed | Mar 31, 2022 |
Key People
Founding team and executive leadership
Flomics Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Decelera Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 14, 2026
Grew 25% QoQ, from 16 to 20 employees.
- Nov 7, 2025
Monthly visitors grew 96% MoM.
Recent news
Latest coverage and updates
- partners_withOct 6, 2026
Flomics and M20 Genomics partner under a collaboration agreement that makes Flomics an authorized single-cell sequencing service provider across Southern Europe, extending both companies' single-cell capabilities and regional life sciences presence.
Flomics Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Flomics Biotech's valuation, stock price, and market status.
Is Flomics Biotech a public or private company?
Flomics Biotech is a private company.
What is the current stock price of Flomics Biotech?
Flomics Biotech is a private company, so its shares have no public market price. Caplight tracks Flomics Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Flomics Biotech worth (valuation)?
Flomics Biotech's valuation is estimated at $10.7M based on funding round data.
Can I buy Flomics Biotech stock?
Flomics Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Flomics Biotech's last funding round?
Flomics Biotech's most recent funding round was Crowdfunding on July 12, 2024.
Who are the main investors in Flomics Biotech?
Key investors in Flomics Biotech include Decelera Ventures.
Will Flomics Biotech IPO soon?
No public IPO plans have been announced for Flomics Biotech.
How can I track Flomics Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Flomics Biotech's shares on secondary markets.